Compare Monthly Costs: Wegovy Available Now vs Mounjaro Shortages
Monthly Cost Reality: Mounjaro vs Wegovy for Weight Loss in the UK
When evaluating Mounjaro vs Wegovy for weight loss, monthly cost planning becomes essential for sustainable treatment. Wegovy offers predictable monthly pricing through EverydayMeds, starting at £79.99 for the 0.25mg starter dose and escalating to £209.99 for the 2.4mg maintenance dose. This transparent pricing structure allows patients to budget effectively across the 16-week dose escalation period and beyond.
Mounjaro, while clinically effective as a dual GIP and GLP-1 receptor agonist, faces significant supply challenges across UK pharmacies. These shortages create unpredictable monthly costs and treatment interruptions, making Wegovy the more reliable choice for consistent weight management support. EverydayMeds maintains steady Wegovy supply through our GPhC-registered pharmacy (#9012878), ensuring your monthly treatment continues uninterrupted.
Wegovy Pricing Structure: Complete Monthly Breakdown
Understanding the complete monthly cost structure helps patients plan their Mounjaro vs Wegovy for weight loss decision effectively. Wegovy follows a mandatory 16-week dose escalation: Month 1 costs £79.99 (0.25mg), Month 2 rises to £94.99 (0.5mg), Month 3 reaches £99.99 (1mg), and Month 4 peaks at £139.99 (1.7mg) before maintenance. From Month 5 onwards, the maintenance dose of 2.4mg costs £209.99 monthly, providing predictable budgeting for long-term weight management.
Our bundle options offer convenience for multi-month planning, with the Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99. New customers benefit from the FIRST40 discount code at checkout, while returning customers use DOSE25 to maintain competitive pricing. This structured approach ensures transparent monthly costs without unexpected price fluctuations common with supply-constrained alternatives.
Clinical Evidence Comparison: Mounjaro vs Wegovy for Weight Loss Efficacy
Both medications demonstrate significant weight management benefits in clinical trials, though direct comparisons require careful interpretation due to different study designs. Wegovy's STEP trials showed patients achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, while Mounjaro's SURMOUNT trials demonstrated similar efficacy ranges with its dual-hormone mechanism. The key consideration becomes treatment accessibility and cost consistency rather than marginal efficacy differences.
The SELECT cardiovascular outcomes trial further supports Wegovy's clinical value, showing a 20% reduction in major cardiovascular events (Wilding et al., NEJM, 2021). This additional cardiovascular benefit may justify the monthly cost investment for patients with weight-related comorbidities, making the Mounjaro vs Wegovy for weight loss decision clearer when considering comprehensive health outcomes alongside monthly budgeting requirements.
How Wegovy Works: GLP-1 Mechanism and Monthly Value
Wegovy functions as a GLP-1 receptor agonist, mimicking natural fullness hormones to reduce appetite and promote satiety after smaller meals. This once-weekly injectable prescription-only medicine works on brain appetite centres, potentially reducing food cravings and supporting sustainable eating pattern changes. Unlike Mounjaro's dual GIP and GLP-1 approach, Wegovy's single-hormone mechanism provides proven weight management support with established monthly cost predictability. The medication must be used alongside a reduced-calorie diet and increased physical activity for optimal results. Monthly injections using the convenient FlexTouch pen system ensure consistent medication levels, supporting steady progress throughout your weight management journey.
EverydayMeds Ordering Process: From Assessment to Delivery
Accessing Wegovy through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, your monthly Wegovy supply ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all supplies meet stringent UK pharmaceutical standards. This streamlined process eliminates the uncertainty often experienced with Mounjaro supply chains, providing reliable monthly medication access essential for consistent weight management progress.
Storage Advantages: Wegovy vs Mounjaro Practical Considerations
Wegovy offers significant storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigerated storage, versus Mounjaro's 21-day limitation. This storage advantage reduces monthly medication waste and provides travel convenience for busy lifestyles. The FlexTouch pen system delivers precise doses throughout the mandatory escalation schedule, from 0.25mg starter doses to 2.4mg maintenance levels. Proper storage at 2-8°C before first use ensures medication potency and therapeutic effectiveness. These practical advantages contribute to the overall monthly value proposition when comparing Mounjaro vs Wegovy for weight loss, particularly for patients requiring flexible medication management options.
Long-term Cost Planning: Annual Investment in Weight Management
Calculating annual costs helps patients understand the true financial commitment when choosing between Mounjaro vs Wegovy for weight loss. After completing the 16-week dose escalation (total cost £414.96), Wegovy maintenance therapy costs £209.99 monthly, equating to £2,519.88 annually for consistent weight management support. This predictable annual investment allows proper financial planning compared to Mounjaro's uncertain supply availability and fluctuating costs across different pharmacy providers.
The STEP trial extensions demonstrate that sustained weight management requires ongoing treatment, with patients regaining approximately two-thirds of lost weight within one year of stopping medication. This clinical reality emphasises the importance of choosing a treatment with reliable monthly supply and predictable costs. EverydayMeds' consistent pricing structure and Reliable Supply availability make Wegovy the practical choice for long-term weight management investment planning.
Secure Your Monthly Supply: Discount Codes and Next Steps
Beginning your weight management journey with Wegovy requires just a few simple steps through our secure online platform. New customers apply discount code FIRST40 at checkout to access our introductory pricing, while returning customers use DOSE25 to maintain competitive monthly rates. Our clinical team provides ongoing support throughout your treatment journey, ensuring optimal results from your monthly investment. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and secure your first month's supply. With reliable monthly delivery and transparent pricing, EverydayMeds makes the Mounjaro vs Wegovy for weight loss decision clear through consistent access and clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
